Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects

被引:103
|
作者
Moriya, Y
Nakamura, T
Horinouchi, M
Sakaeda, T
Tamura, T
Aoyama, N
Shirakawa, T
Gotoh, A
Fujimoto, S
Matsuo, M
Kasuga, M
Okumura, K [1 ]
机构
[1] Kobe Univ, Sch Med, Dept Hosp Pharm, Kobe, Hyogo 650, Japan
[2] Kyoto Pharmaceut Univ, Dept Environm Biochem, Yamashina Ku, Kyoto 6078414, Japan
[3] Kobe Univ, Sch Med, Dept Endoscopy, Kobe, Hyogo, Japan
[4] Kobe Univ, Sch Med, Dept Clin Genet, Chuo Ku, Kobe, Hyogo 6500017, Japan
[5] Kobe Univ, Sch Med, Int Ctr Med Res, Chuo Ku, Kobe, Hyogo 6500017, Japan
[6] Kobe Univ, Grad Sch Med, Fac Med,Div Diabet Digest & Kidney Dis, Dept Clin Mol Med,Chuo Ku, Kobe, Hyogo 6500017, Japan
[7] Kobe Univ, Grad Sch Med, Dept Organ Therapeut, Fac Med,Div Urol,Chuo Ku, Kobe, Hyogo 6500017, Japan
关键词
P-glycoprotein; multidrug resistance-associated protein; genetic polymorphism; gene expression; duodenal enterocyte;
D O I
10.1248/bpb.25.1356
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, we examined whether polymorphisms in the ATP-binding cassette (ABC) transporter genes, MDR1, MRP1 and MRP2, were associated with their respective mRNA expression levels in duodenal enterocytes of 13 healthy Japanese volunteers. MDR1 genotypes of T-129C, G2677(A,T) and C3435T, MRP1 genotypes of G128C, C218T, G2168A and G3173A, and MRP2 genotypes of C-24T, G1249A, C2302T, C2366T and G4348A were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or direct sequencing. Mutations T-129C, G2677(A,T) and C3435T of MDR1 gene were found at allele frequencies of 2/26, 16/26 and 12/26, respectively. Mutations G2168A of the MRP1 gene and C-24T of the MRP2 gene were also found at allele frequencies of 1/26 and 6/26, respectively, whereas other mutations were not detected in MRP1 and MRP2 genes. The relative concentrations (mean+/-S.E.) of MDR1 mPNA to villin mRNA were 0.38+/-0.15, 0.56+/-0.14 and 1.13+/-0.42 in the subjects with C/C-3435, C/T-3435 and T/T-3435, respectively, which supported the lower serum concentrations of digoxin after single oral administration in the subjects with the mutant T-allele at position 3435. Genetic collaboration between positions 3435 and 2677 was suggested, and those in G/G(2677), G/(A,T)(2677) and T/(A,T)(2677) were 0.16+/-0.05, 1.10+/-0.40, and 0.63+/-0.16, respectively (p = 0.107). However, there was no remarkable effect of the G2168A of the MRP1 gene or of C-24T of the MRP2 gene on the relative MRP1 or MRP2 mRNA concentrations, respectively.
引用
收藏
页码:1356 / 1359
页数:4
相关论文
共 50 条
  • [21] Expression and localization of BCRP, MRP1 and MRP2 in intestines, liver and kidney in horse
    Tyden, E.
    Bjornstrom, H.
    Tjalve, H.
    Larsson, P.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2010, 33 (04) : 332 - 340
  • [22] Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver
    Chisaki, Ikumi
    Kobayashi, Masaki
    Itagaki, Shirou
    Hirano, Takeshi
    Iseki, Ken
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2009, 1788 (11): : 2396 - 2403
  • [23] Expression profile of drug resistance genes MDR1, MRP1, MRP3, BCRP E LRP in childhood acute leukemias
    de Freitas Cortez, Maria Anelica Abdalla
    Scrideli, Carlos Alberto
    Valera, Elvis Terci
    Yunes, Jose Andres
    Brandalise, Silvia Regina
    Toledo, Silvia
    de Martino Lee, Maria Lucia
    Petrilli, Antonio Sergio
    Odone Filho, Vicente
    Bendit, Israel
    Tone, Luiz Gonzaga
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 436 - 437
  • [24] Expression of multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer
    Faneyte, I. F.
    Kristel, P. M. P.
    van de Vijver, M. J.
    EJC SUPPLEMENTS, 2004, 2 (03): : 106 - 107
  • [25] Expression of the mRNA Levels for MDR1, MRP1, MRP4, and MRP5 IN HIV Antiretroviral Naive Patients: Follow-up at 48 Weeks After the Beginning of Therapy
    Falasca, Francesca
    Maida, Paola
    Montagna, Claudia
    Antonelli, Laura
    d'Ettorre, Gabriella
    Monteleone, Katia
    Antonelli, Guido
    Turriziani, Ombretta
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (02) : E54 - E56
  • [26] THE EXPRESSION OF MULTIDRUG RESISTANCE GENES (MDR1, MRP1, BCRP, LRP) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Cioch, M.
    Kocki, J.
    Jarosz, M.
    Dmoszynska, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 533 - 533
  • [27] Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs
    Annalisa Nannelli
    Francesco Rossignolo
    Roberto Tolando
    Paolo Rossato
    Mario Pellegatti
    Vincenzo Longo
    P. Giovanni Gervasi
    Molecular and Cellular Biochemistry, 2010, 337 : 133 - 143
  • [28] Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs
    Nannelli, Annalisa
    Rossignolo, Francesco
    Tolando, Roberto
    Rossato, Paolo
    Pellegatti, Mario
    Longo, Vincenzo
    Gervasi, P. Giovanni
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2010, 337 (1-2) : 133 - 143
  • [29] EVALUATING THE IMPACT OF MRP1 AND MRP2 POLYMORPHISMS ON THE PHARMACORESISTANCE TO IMATINIB TREATMENT AMONG CML PATIENTS
    Au, A.
    Baba, A. A.
    Goh, S. A.
    Wahid, F. S. A.
    Teh, A.
    Elias, M. H.
    Ankathil, R.
    ANNALS OF ONCOLOGY, 2013, 24
  • [30] FUNCTIONAL CHARACTERIZATION OF ETHIONAMIDE AND PROTHIONAMIDE BY MDR1, MRP1/2, IN VITRO.
    Lee, Y.
    Lim, S.
    Cho, M.
    Yoon, Y.
    Lee, D.
    Parvez, M.
    Shin, H.
    Shin, J. -G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S35 - S35